SCHEMBL4993524

SCHEMBL4993524

CC(CCC=O)CCC1CCCCC1

nearest known ligand 0.40

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 1/20 0.40
ADH1B P00325 2/20 0.38
ADH1C P00326 2/20 0.38
ADH1A P07327 2/20 0.38
ADH4 P08319 1/20 0.38
ADH7 P40394 1/20 0.38
CYP1A2 P05177 1/20 0.36
METAP2 P50579 1/20 0.33
BCHE P06276 1/20 0.32
GLA P06280 1/20 0.32
HPGD P15428 1/20 0.32
MAPT P10636 1/20 0.32
SIGMAR1 Q99720 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4993518 1.00 METAP1 (0.40) METAP1ADH1BADH1CADH1AADH4
SCHEMBL7879516 0.83 METAP1 (0.41) METAP1ADH1BADH1CADH1AADH4
SCHEMBL6564265 0.81 METAP1 (0.38) METAP1ADH1BADH1CADH1AADH4
SCHEMBL4986356 0.79 ALOX15 (0.52) METAP1CYP1A2GLAHPGD
SCHEMBL4986361 0.79 ALOX15 (0.52) METAP1CYP1A2GLAHPGD
SCHEMBL4986353 0.79 ALOX15 (0.52) METAP1CYP1A2GLAHPGD
SCHEMBL28058465 0.79 METAP1 (0.43) METAP1CYP1A2METAP2BCHEHPGD
SCHEMBL27457627 0.76 METAP1 (0.35) METAP1CYP1A2METAP2MAPT
SCHEMBL826390 0.75 ADH1B (0.50) METAP1ADH1BADH1CADH1AADH4
SCHEMBL21114254 0.75 ADH1B (0.50) METAP1ADH1BADH1CADH1AADH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7388023-B2 Amino acids with affinity for the α2δ-protein WARNER-LAMBERT COMPANY LLC (US) 2008-06-17 US disclosed
US-20070129550-A1 AMINO ACIDS WITH AFFINITY FOR THE ALPHA-2-DELTA-PROTEIN WANER-LAMBERT COMPANY LLC (US) 2007-06-07 US disclosed
US-7179934-B2 Amino acids with affinity for the α2δ-protein WARNER-LAMBERT COMPANY LLC (US) 2007-02-20 US disclosed
CN-1886363-A Amino acids with affinity for the alpha2delta-protein WARNER LAMBERT CO (US) 2006-12-27 CN disclosed
EP-1667957-A2 AMINO ACIDS WITH AFFINITY FOR THE ALPHA2DELTA-PROTEIN Warner-Lambert Company LLC (US) 2006-06-14 EP disclosed
US-20050124668-A1 Amino acids with affinity for the alpha2delta-protein WARNER-LAMBERT COMPANY LLC 2005-06-09 US disclosed
US-20050101643-A1 Amino acids with affinity for the alpha2delta-protein WARNER-LAMBERT COMPANY LLC 2005-05-12 US disclosed
WO-2005030700-A2 AMINO ACIDS WITH AFFINITY FOR THE ALPHA2DELTA-PROTEIN WARNER-LAMBERT COMPANY LLC (US) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124668-A1 Amino acids with affinity for the alpha2delta-protein SCN2A, SCN1A, OPRD1 METAP1 1825/4885ADH1B 3410/4885ADH1C 1728/4885
US-20070129550-A1 AMINO ACIDS WITH AFFINITY FOR THE ALPHA-2-DELTA-PROTEIN SCN2A, OPRD1, SCN1A METAP1 1443/4885ADH1B 3324/4885ADH1C 1874/4885
US-20050101643-A1 Amino acids with affinity for the alpha2delta-protein SCN2A, OPRD1, SCN1A METAP1 1583/4885ADH1B 3251/4885ADH1C 1637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.